Corona 360 – Previous Interviews

Corona360 In-Conversation

“Corona360 In-Conversation” is a series of live moderated interviews bringing together 3 biopharma industry experts and 2 solution providers into a panel discussion to find solutions to mitigate challenges to current problems! Corona360 In-Conversation will bring you one webcast every two weeks  from now until the end of 2020, bridging your questions on the current circumstances to frontliners in SARS-CoV-2 vaccine development efforts. So stay tuned for further updates!

Previous Interviews

As part of the Corona360 – In Conversation series, the Accelerating the Fill/Finish Line to Vial SARS-CoV-2 Vaccines for Upcoming Clinical Trials live moderated discussion aims at addressing clinical trial and fill/finish challenges faced so that we will be well-equipped to address additional waves or a post-pandemic scenario where SARS-CoV-2 continues to circulate as a seasonal virus.

As part of the Corona360 – In Conversation series, the Coping with the Clinical Trial Challenges of SARS-CoV-2 Vaccines live moderated discussion aims at addressing R&D and clinical trial challenges faced so that we will be well-equipped to address additional waves or a post-pandemic scenario where SARS-CoV-2 continues to circulate as a seasonal virus.

As part of the Corona360 – In Conversation series, the Developing Standardized Animal Models to Evaluate SARS-CoV-2 Vaccine Effectiveness live moderated discussion aims to discuss challenges and solutions pertaining to animal models during pre-clinical studies so that companies will be well-equipped to address additional waves or a post-pandemic scenario where SARS-CoV-2 continues to circulate as a seasonal virus.

As part of the Corona360 – In Conversation series, the Tackling Real Time Monitoring Challenges During Flight Disruptions live moderation aims to discuss solutions and future plans on coping with travel restriction and disruption so that companies will be well-equipped to address additional waves or a post-pandemic scenario where SARS-CoV-2 continues to circulate as a seasonal virus.

As part of the Corona360 – In Conversation series, the Asia’s SARS-CoV-2 Vaccine Development Challenges live moderated discussion aims at addressing R&D and clinical trial challenges faced so that we will be well-equipped to address additional waves or a post-pandemic scenario where SARS-CoV-2 continues to circulate as a seasonal virus.

FAQs: Clarify Your Doubts!

Which platform is being used to host the interview?

We will be streaming the interview on our Youtube Live account. Details on how to tune in will be shared with registered attendees.

How do I log on and view the interview?

Choose an interview you would like to attend and complete the registration process on the interview webpage. A confirmation email will be sent to you upon registration, which will contain the details on how to tune into the interview session.

How long is each interview?

Each interview will be between 1 – 1.5 hours approx.

Will interviewees be able to share materials (presentation slides, supporting documents etc.) via the interview hosting platform?

During the streaming of the interview, interviewees will be able to share their screens with you. However, any supplementary material will be sent exclusively to you via email before and/or after the interview.

Market Intelligence